SG vs VRTX · P/E 71, rev $679.5M vs P/E 30, rev $12.00B
Sweetgreen Inc (SG) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Sweetgreen Inc (SG) is a restaurants company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported SG revenue for 2025-12-28 was $679.5M. Net income was -$134.1M. Revenue was up 0.4% from 2024-12-29 to 2025-12-28. SG currently screens at market cap $1.01B and trailing P/E 71.0.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
SG currently screens at market cap $1.01B and trailing P/E 71.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the SG and VRTX stock pages for the full models.
Not investment advice.